Antitrust Investigation

New research shows a telehealth model boosting GLP-1 results to over 26% weight loss, but its reliance on unapproved compounded drugs raises safety flags.

Lawyers for Tirana's detained mayor accuse a U.S.-backed anti-graft unit of due process violations, urging Washington to intervene in the high-stakes case.

A petition filed with the Dept. of Commerce alleges a major railcar firm is evading duties on parts from China and Mexico, setting up a major trade battle.

After its Alzheimer's drug failed amidst controversy, Cassava Sciences rebrands as Filana Therapeutics, betting its future on a rare epilepsy disorder.

As Capricor prepares its Q4 earnings call, all eyes are on its DMD drug Deramiocel's FDA path, financial health, and next-gen exosome technology.

Investors drop their petition over Coupang's treatment, but the US government now plans a broader trade investigation into South Korea's digital practices.

Facing volatile markets, AVAX One pushes for regulatory clarity at the DC Blockchain Summit, aiming to legitimize Avalanche for institutional investors.

A new nicotine-free pouch powered by a caffeine metabolite enters the market, led by a controversial founder aiming to redefine focus and energy.

A new poll reveals overwhelming public opposition to a federal plan to stockpile glyphosate, fueled by billions in lawsuits and a retracted safety study.

Hawaiian Electric Industries reports a dramatic financial turnaround, but the utility's path forward is defined by massive investments in grid safety and renewables.

As state attorneys general ramp up multi-state investigations, Stateside Associates brings on a seasoned expert to help clients navigate the complex landscape.

Bolstered by strong 2025 earnings, Extendicare is acquiring CBI Home Health to dominate Canada's home care market while boosting shareholder returns.

NuScale Power touts a 'breakthrough year' with landmark deals, but staggering financial losses and partner scrutiny test its path to commercialization.

Facing a 5-day suspension for failures tied to the Jontay Porter scandal, PointsBet Canada is claiming human error while the AGCO calls it a systemic failure.

Thermon Group's $2.2 billion sale to CECO Environmental faces legal scrutiny, leaving shareholders to question if the offer is fair amid record profits.

Keurig's ubiquitous K-Cup pods are now recyclable in Ontario, marking a pivotal test for the province's new producer-funded waste system.

RCI faces a Nasdaq deadline amid late financial reports linked to a NY indictment. Can strong profits and a new CEO team navigate the regulatory storm?

At a massive festival, an AI avatar of yogi Sadhguru offered guidance via hologram, merging ancient wisdom with futuristic tech. But what does this mean?

A federal court ruling against Corcept Therapeutics clears a key legal hurdle for Teva's generic Cushing's syndrome drug, rattling investors.

The Pokémon Company is buying its largest US distributor, a move to fix supply issues that could reshape the entire collectibles industry for years to come.